Минеральная плотность кости у девочек с синдромомШерешевского-Тернера в допубертатном возрасте ивлияние на нее терапии рекомбинантным гормономроста
https://doi.org/10.14341/osteo2009119-22
Аннотация
Список литературы
1. Дедов И.И., Петеркова В.А., Волеводз Н.Н., Семичева Т.В. Синдром Шерешевского-Тернера (патогенез, клиника, диагностика, лечение): Методические рекомендации. Москва, 2002.
2. American Association of Clinical Endocrinologists (AACE). American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children-2003 update. Endocr. Pract. 2003; 9(1): 64-76.
3. Ari M., Bakalov V.K., S. Hill, and С.A. Bondy. The Effects of Growth Hormone Treatment on Bone Mineral Density and Body Composition in Girls with Turner Syndrome. J. Clin. Endocrinol. Metab., 2006; 91(11): 4302-4305.
4. Bakalov V.K., Axelrod L., Baron J., Hanton L., Nelson .LM., Reynolds J.C., Hill S., Troendle J., Bondy C.A. Selective reduction in cortical bone mineral density in Turner syndrome independent of ovarian hormone deficiency. J Clin Endocrinol Metab 2003; 88: 5717-5722
5. Bakalov V.K., Van P.L., Baron J., Reynolds J.C., Bondy C.A. Growth hormone therapy and bone mineral density in Turner syndrome. J Clin Endocrinol Metab 2004; 89: 4886-488.
6. Betts P.R., Butler G.E., Donaldson C. A decade of growth hormone treatment in girls with Turner syndrome in the UK. Arch Dis Child 1999; 80 (3): 221-225.
7. Carel J.C., Mathivon L., Gendrel C., Ducret J.P., Chaussain J.L. Near normalization of fnal height with adapted doses of growth hormone in Turner's syndrome. J Clin Endocrinol Metab 1998; 83: 1462-1466
8. Carrascosa A., Gussinye M., Terradas P., Yeste D., Audi L., Vicens-Calvet E. Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients. J Bone Miner Res 2000; 15: 2005-2010.
9. Chernausek S.D., Attie K.M., Cara J.F., Rosenfeld R.G. Growth Hormone Therapy of Turner Syndrome: The Impact of Age of Estrogen Replacement on Final Height. J Clin Endocrinol Metabоl 2000; 85 (7): 2439-2445.
10. Elsheikh M., Dunger D.B., Conway G.S., and Wass J.A. Turner's Syndrome in Adulthood. Endocr Rev 2002; 23 (1): 120-140.
11. Gravholt C.H. Epidemiological, endocrine and metabolic features in Turner syndrome. Europ. J Endocrinol 2004; 151: 657-687.
12. Greulich W.W., Pyle S.I. Radiographic atlas of skeletal development of the hand and wrist, 2nd ed. Stanford: Stanford University Press, 1959.
13. Hochberg Z., Zadik Z. Final height in young women with Turner syndrome after GH therapy: an open controlled study. Europ. J Endocrinol 1999; 141: 218-224.
14. Lanes R., Gunczler P., Esaa S., Weisinger J.R. The effect of short-and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study. Clin Endocrinol (Oxf) 2002; 57: 725-730.
15. Monson J.P., Drake W.M., Carroll P.V., Weaver J.U., Rodriguez-Arnao J., Savage M.O. Infuence of growth hormone on accretion of bone mass. Horm Res 2002; 58: 52-56.
16. Neely E.K., Marcus R., Rosenfeld R.G., Bachrach L.K. Turner syndrome adolescents receiving growth hormone are not osteopenic. J Clin Endocrinol Metab 1993; 76: 861-866.
17. Rosenfeld R.G., Attie K.M., Frane .J, et al Growth hormone therapy of Turner's syndrome: benefcial effect on adult height. J Pediatr 1998; 132: 319-324.
18. Sas T.C., de Muinck Keizer-Schrama S.M., Stijnen T., van Teunenbroek A., van Leeuwen W.J., Asarf A., van Rijn R.R., Drop S.L. Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response study. Pediatr Res 2001; 50: 417-422.
19. Shaw N.J., Rehan V.K., Husain S., Marshall T., Smith C.S. Bone mineral density in Turner's syndrome: a longitudinal study. Clin Endocrinol (Oxf) 1997; 47: 367-370.
20. Suganuma N., Furuhashi M., Hirooka T., Moriwaki T., Hasegawa Y., Mori O., Ogawa M. Bone mineral density in adult patients with Turner's syndrome: analyses of the effectiveness of GH and ovarian steroid hormone replacement therapies. Endocr. J 2003; 50: 263-269.
21. Tanner J.M., Whitehouse R.H., Takaishi M. Standards from birth to maturity for height, height velocity and weight velocity: British children, 1965 Part II. Arch Dis Child 1966; 41: 613-635.
22. Tanner J.M., Whitehouse R.H Clinical longitudinal standard for height, weight, height velocity, weight velocity and stages of puberty. Arch Dis Child 1976; 51: 170-171.
23. The Turner Syndrome Consensus Study Group Care of Girls and Women with Turner Syndrome: A Guideline of theTurner Syndrome Study Group. J Clin Endocrin Metab 2006; (10): 1310-1374.
Рецензия
Для цитирования:
., ., . Минеральная плотность кости у девочек с синдромомШерешевского-Тернера в допубертатном возрасте ивлияние на нее терапии рекомбинантным гормономроста. Остеопороз и остеопатии. 2009;12(1):19-22. https://doi.org/10.14341/osteo2009119-22
For citation:
Volevodz N.N., Pankratova M.S., Sazonova N.I. Mineral'naya plotnost' kosti u devochek s sindromomShereshevskogo-Ternera v dopubertatnom vozraste ivliyanie na nee terapii rekombinantnym gormonomrosta. Osteoporosis and Bone Diseases. 2009;12(1):19-22. (In Russ.) https://doi.org/10.14341/osteo2009119-22
Просмотров: 257
Контент доступен под лицензией Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Послать статью по эл. почте 
